ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.06
-0.06 (-0.66%)
At close: Mar 6, 2026, 4:00 PM EST
9.13
+0.07 (0.77%)
After-hours: Mar 6, 2026, 7:28 PM EST
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $895.57 million as of March 6, 2026. Its market cap has decreased by -21.77% in one year.
Market Cap
895.57M
Enterprise Value
777.16M
1-Year Change
-21.77%
Ranking
Category
Stock Price
$9.06
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $895.57M, an increase of 57.60%. That is a compound annual growth rate of 14.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 895.57M | -22.23% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 941.66M |
| Cullinan Therapeutics | 929.86M |
| Valneva SE | 920.15M |
| Maravai LifeSciences Holdings | 912.59M |
| Fortrea Holdings | 898.54M |
| SpyGlass Pharma | 888.91M |
| uniQure | 888.90M |
| Arbutus Biopharma | 871.23M |